MYC regulation of glutamine–proline regulatory axis is key in luminal B breast cancer
Madeleine L. Craze(University of Nottingham), Andrew R. Green(Nottingham Biomedical Research Centre)
Cited by 96
Related Papers
MYC functions are specific in biological subtypes of breast cancer and confers resistance to endocrine therapy in luminal tumours
|British Journal of Cancer|2016|125
Biological and clinical significance of PARP1 protein expression in breast cancer
|Breast Cancer Research and Treatment|2014|83
Lost in translation: preclinical studies on 3,4‐methylenedioxymethamphetamine provide information on mechanisms of action, but do not allow accurate prediction of adverse events in humans
|British Journal of Pharmacology|2011|75
LitSumm: Large language models for literature summarisation of non-coding RNAs
|arXiv (Cornell University)|2023|4